Trial intelligence / Profile preview

Bimatoprost for Pediatric Eyelash Hypotrichosis

NCT01023841Phase 4Completed

Sponsor
Allergan
Start
Jun 2010
Primary completion
Nov 2012
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 4 trial of bimatoprost in eyelash hypotrichosis, sponsored by Allergan. Started Jun 2010; status: completed.

02

Drugs

bimatoprost
03

Conditions

eyelash hypotrichosis

Beyond the preview

Go deeper on NCT01023841.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01023841.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call